Delivery Order SPE2DB24D3015-SPE2DB25FFXUR

Award Date 1/23/25
Potential Completion Date 2/13/25
Potential Value $7.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award by the Defense Logistics Agency (DLA) is a delivery order awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,558.78 firm fixed-price contract is for the supply of ERLEADA 60 MG TABLET UU 120S, a pharmaceutical product, to support military healthcare programs. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,558.78 firm fixed-price delivery order is for the supply of ERLEADA 60 MG TABLET UU 120S, a pharmaceutical product. The contract has a period of performance through January 8, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $7,352.49, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of ERLEADA 240 MG TABLET UU 30S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of March 11, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award, valued at $15,117.58, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. The contract covers the delivery of ERLEADA 60 MG TABLET UU 120S, a pharmaceutical product, to support military...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,558.78 firm fixed-price delivery order is for 120 units of the medication ERLEADA 60 MG TABLET, with a performance period ending on July 29, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which enables the company to supply a...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The $7,106.87 Firm Fixed Price delivery order is for the supply of ERLEADA 240 MG TABLET UU 30S, a prescription medication. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical,...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,558.78 firm fixed-price delivery order is for the medical product "ERLEADA 60 MG TABLET UU 120S" and has an ultimate completion date of March 27, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,704.98 firm-fixed-price delivery order is for the supply of ERLEADA 240 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of July 3, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award, valued at $22,057.47, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ERLEADA 240 MG TABLET, a prescription medication, to support military healthcare programs. The contract is a Delivery Order issued under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order (DO) valued at $7,558.78 with a firm fixed price. The contract is for the supply of ERLEADA 60 MG TABLET UU 120S, a pharmaceutical product. This contract is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
  • SPE2DB24D3015
    Indefinite Delivery Contract
  • SPE2DB24D3015-SPE2DB25FFXUR
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,558.78 Firm Fixed Price Delivery Order contract is for the supply of ERLEADA 60 MG TABLET UU 120S, a specialty medication.

The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC encompasses critical medical commodities across multiple therapeutic areas.

The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen is the prime contractor, and there is no information provided about major subcontractors. The DLA, a defense agency, is the funding agency for this award, which aligns with the company's significant focus on supporting military and veterans' healthcare systems through its federal contract portfolio.

Generated 5/21/25, 10:02 AM